34.8. The following assisted procreation services required for IVF purposes are considered insured services:(a) services required to retrieve sperm, including the visit and sperm washing, and a single retrieval of sperm by means of a percutaneous epididymal sperm aspiration or of a surgical or microsurgical testicular sperm extraction, according to medical indication;
(b) services required for ovarian stimulation;
(c) services required for a single egg retrieval procedure from only one person;
(d) standard fertilization and embryo culture services carried out in the laboratory, including assisted hatching services and sperm microinjection (ICSI) services;
(e) services required to transfer a fresh or frozen embryo or, in accordance with the guidelines drawn up under section 10 of the Act respecting clinical and research activities relating to assisted procreation (chapter A-5.01), a maximum of 2 fresh or frozen embryos; (f) either one sperm straw from a single retrieval in the context of a directed donation or one sperm straw from a sperm bank;
(g) freezing and storage of embryos for a maximum of 1 year; and
(h) embryo biopsy and preimplantation genetic testing for all embryos obtained from an IVF cycle.
Those services are considered insured services for a single IVF cycle, which may however include a second ovulatory cycle if, during the first cycle, the number of follicles is insufficient and egg retrieval has not taken place.
The services referred to in subparagraph h of the first paragraph are considered to be insured only if the embryos were created using the reproductive material of a member of the assisted procreation project who is at high risk of conceiving a child with a monogenic hereditary disease or an inherited chromosomal disorder resulting in a serious, disabling or fatal disease or abnormality, whether the condition starts in childhood or adulthood, and for which there is no treatment available to neutralize its serious, disabling or fatal nature. They are not considered insured services if they are intended to:(a) detect embryos that are carriers of recessive diseases or abnormalities when only one parent is a carrier of the disease or abnormality;
(b) detect an embryo with susceptibility genes for multifactorial diseases;
(c) select an embryo in order to make it a donor of tissues or stem cells only;
(d) select the sex of a child, except in the case of an x-linked disease or abnormality;
(e) voluntarily produce a child with disabilities.
S.Q. 2021, c. 2, s. 32; 245-2024O.C. 245-2024, s. 512.